Nyxoah SA Ordinary Shares (NYXH) Stock: Buy, Sell, or Hold?
NYXH - Nyxoah SA Ordinary Shares
$1.36
0.03 (2.26%)
▲
5d:
-6.21%
30d:
-9.93%
90d:
-23.16%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When NYXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NYXH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NYXH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NYXH is currently trading at $1.36, which is considered oversold relative to its 30-day fair value range of $1.42 to $1.62.
Technical Outlook: Technically, NYXH is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.67.
Market Sentiment: NYXH scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.21 (+209.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NYXH is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.67.
Market Sentiment: NYXH scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.21 (+209.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.42 -
$1.62
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 209.9% below Wall St target ($4.21)
- CAUTION: Bottoming setup, but lagging the sector by 37% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-6.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.42 -
$1.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.67
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.85
Wall Street Target
$4.21
(+209.9%)
Revenue Growth (YoY)
472.8%
Share & Embed Analysis
Last updated: October 03, 2026 5:34 AM ET
Data refreshes hourly during market hours. Next update: 6:34 AM
Data refreshes hourly during market hours. Next update: 6:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NYXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
